Paxlovid associated with decreased hospitalization rate among adults with COVID-19 - United States, April-September 2022.
Saved in:
| Title: | Paxlovid associated with decreased hospitalization rate among adults with COVID-19 - United States, April-September 2022. |
|---|---|
| Authors: | Shah MM; Coronavirus and Other Respiratory Viruses Division (proposed), National Center for Immunization and Respiratory Diseases, CDC, Verona, Wisconsin. Electronic address: bgn3@cdc.gov., Joyce B; Epic Research, Epic Systems Corporation, Verona, Wisconsin., Plumb ID; Coronavirus and Other Respiratory Viruses Division (proposed), National Center for Immunization and Respiratory Diseases, CDC, Verona, Wisconsin., Sahakian S; Epic Research, Epic Systems Corporation, Verona, Wisconsin., Feldstein LR; Coronavirus and Other Respiratory Viruses Division (proposed), National Center for Immunization and Respiratory Diseases, CDC, Verona, Wisconsin., Barkley E; Epic Research, Epic Systems Corporation, Verona, Wisconsin., Paccione M; Epic Research, Epic Systems Corporation, Verona, Wisconsin., Deckert J; Epic Research, Epic Systems Corporation, Verona, Wisconsin., Sandmann D; Epic Research, Epic Systems Corporation, Verona, Wisconsin., Gerhart JL; Epic Research, Epic Systems Corporation, Verona, Wisconsin., Hagen MB; Coronavirus and Other Respiratory Viruses Division (proposed), National Center for Immunization and Respiratory Diseases, CDC, Verona, Wisconsin. |
| Source: | American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons [Am J Transplant] 2023 Jan; Vol. 23 (1), pp. 150-155. Date of Electronic Publication: 2023 Jan 11. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 100968638 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-6143 (Electronic) Linking ISSN: 16006135 NLM ISO Abbreviation: Am J Transplant Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
